A team of researchers has shown that a molecule called Cyclophilin D (CypD) interacts with amyloid beta (AB) peptide, the main constituent of plaques in the brains of Alzheimer's patients, within the mitochondria.
The study involving a transgenic mouse model of Alzheimer's disease suggests that blocking CypD and development of surrounding mitochondrial targets may be viable therapeutic strategies for the prevention and treatment of Alzheimer's disease, reports Nature.
Brain Depression - Animation
Interactive section of Medindia provides information about chemistry of Brain depression
Advertisement
Study leader Shi Du Yan, professor of clinical pathology in the Department's of Pathology and Surgery and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center, says that this work describes how this mitochondrial process may be linked to synaptic failure in Alzheimer's disease.
During the study, Dr. Yan and colleagues observed that the cortical mitochondria isolated from Alzheimer's disease mice lacking CypD were resistant to AB- and Ca2+-induced mitochondria swelling and permeability transition, increased calcium buffering capacity, and attenuate generation of mitochondrial ROS.
![Know Your Nervous System]( "Know Your Nervous System")
The Central nervous system consists of the brain, the spinal cord, and the body's nerve network. This complex system is based on one kind of cell the neurons.
Also, they found that CypD-deficient neurons protect against AB- and oxidative stress-induced cell death.
Importantly, they researchers found that deficiency of CycD greatly improved the learning, memory, and synaptic function of an Alzheimer's disease mouse model and alleviated AB-mediated reduction of long-term potentiation (LTP).
Thus, the CypD/AB-mediated mitochondrial permeability transition pore directly links to the cellular and synaptic perturbation relevant to the pathogenesis of Alzheimer's disease.
The study is published in the Sept. 21 on-line edition of Nature Medicine.
Source: ANI
SK
Know Your Nervous System
The Central nervous system consists of the brain, the spinal cord, and the body's nerve network. This complex system is based on one kind of cell the neurons.
Advertisement
Also, they found that CypD-deficient neurons protect against AB- and oxidative stress-induced cell death.
Importantly, they researchers found that deficiency of CycD greatly improved the learning, memory, and synaptic function of an Alzheimer's disease mouse model and alleviated AB-mediated reduction of long-term potentiation (LTP).
Thus, the CypD/AB-mediated mitochondrial permeability transition pore directly links to the cellular and synaptic perturbation relevant to the pathogenesis of Alzheimer's disease.
The study is published in the Sept. 21 on-line edition of Nature Medicine.
Source: ANI
SK
Prions Prevent Alzheimer’s Disease
A role for prion proteins, the much debated agents of mad cow disease and vCJD, has been identified.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Mental Health News
Disadvantaged urban areas and depression symptoms associated with premature aging.
There is an urgent need for mental health care in injured children after firearm injuries.
Recently, a noteworthy transformation has occurred, with 81 percent of workplaces now placing increased emphasis on employee mental health.
Individuals with higher intelligence scores demonstrated faster thinking exclusively in simple tasks, while they encountered longer solving times for complex problems.
Individuals who have abnormal protein deposits in their brains and also experience more severe sleep apnea are more likely to have smaller volumes in a specific area of the brain.